2023 Q2 Form 10-Q Financial Statement

#000165156223000006 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $153.7M $147.6M $120.4M
YoY Change 23.2% 22.59% 36.3%
Cost Of Revenue $74.00M $70.17M $42.80M
YoY Change 59.66% 63.95% 10.24%
Gross Profit $79.70M $77.47M $77.63M
YoY Change 1.65% -0.21% 56.71%
Gross Profit Margin 51.85% 52.47% 64.46%
Selling, General & Admin $76.94M $78.40M $76.85M
YoY Change -5.38% 2.02% 67.94%
% of Gross Profit 96.53% 101.2% 98.99%
Research & Development $41.29M $43.81M $37.96M
YoY Change -8.11% 15.42% 71.43%
% of Gross Profit 51.8% 56.55% 48.89%
Depreciation & Amortization $5.331M $5.511M $4.182M
YoY Change 20.09% 31.78% 42.68%
% of Gross Profit 6.69% 7.11% 5.39%
Operating Expenses $118.2M $116.5M $114.8M
YoY Change -6.35% 1.52% 69.08%
Operating Profit -$38.52M -$39.08M -$37.17M
YoY Change -19.47% 5.13% 102.44%
Interest Expense $8.240M $8.037M $335.0K
YoY Change 884.47% 2299.1% 318.75%
% of Operating Profit
Other Income/Expense, Net -$8.000K $102.0K -$425.0K
YoY Change -99.32% -124.0% 5971.43%
Pretax Income -$30.14M -$30.94M -$37.26M
YoY Change -37.42% -16.97% 103.74%
Income Tax $1.599M $1.426M $1.008M
% Of Pretax Income
Net Earnings -$31.74M -$32.36M -$38.27M
YoY Change -35.66% -15.43% 105.05%
Net Earnings / Revenue -20.65% -21.92% -31.78%
Basic Earnings Per Share -$0.21 -$0.22 -$0.27
Diluted Earnings Per Share -$0.21 -$0.22 -$267.6K
COMMON SHARES
Basic Shares Outstanding 150.7M shares 149.6M 143.3M
Diluted Shares Outstanding 150.3M shares 149.0M shares 143.0M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $716.9M $779.5M $780.4M
YoY Change -8.46% -0.12% 177.93%
Cash & Equivalents $361.2M $267.8M $361.3M
Short-Term Investments $355.7M $511.7M $419.1M
Other Short-Term Assets $46.89M $41.32M $43.30M
YoY Change 9.07% -4.58% 24.43%
Inventory
Prepaid Expenses
Receivables $73.21M $68.20M $54.19M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $837.0M $889.0M $877.9M
YoY Change -5.27% 1.26% 149.97%
LONG-TERM ASSETS
Property, Plant & Equipment $36.04M $26.81M $26.40M
YoY Change 29.35% 1.54% 25.25%
Goodwill
YoY Change
Intangibles $9.179M $8.470M $9.703M
YoY Change 0.15% -12.71% -5.91%
Long-Term Investments
YoY Change
Other Assets $36.48M $31.39M $15.74M
YoY Change 100.03% 99.42% 67.35%
Total Long-Term Assets $81.70M $75.08M $68.96M
YoY Change 18.69% 8.88% 8.39%
TOTAL ASSETS
Total Short-Term Assets $837.0M $889.0M $877.9M
Total Long-Term Assets $81.70M $75.08M $68.96M
Total Assets $918.7M $964.1M $946.9M
YoY Change -3.54% 1.82% 128.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $88.72M $93.23M $53.90M
YoY Change 60.37% 72.98% 30.19%
Accrued Expenses $30.68M $25.10M $24.10M
YoY Change 24.91% 4.18% 47.83%
Deferred Revenue $138.6M $130.9M $106.8M
YoY Change 19.92% 22.53% 25.31%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $284.7M $273.8M $203.8M
YoY Change 26.91% 34.34% 29.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $7.554M $1.730M $955.0K
YoY Change 727.38% 81.15% 53.29%
Total Long-Term Liabilities $7.554M $1.730M $955.0K
YoY Change 727.38% 81.15% 53.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $284.7M $273.8M $203.8M
Total Long-Term Liabilities $7.554M $1.730M $955.0K
Total Liabilities $292.2M $283.0M $218.2M
YoY Change 23.51% 29.73% 22.15%
SHAREHOLDERS EQUITY
Retained Earnings -$728.2M -$696.5M -$527.0M
YoY Change 26.35% 32.15% 45.5%
Common Stock $2.000K $1.000K $1.000K
YoY Change 100.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $59.23M $4.701M $4.701M
YoY Change 1159.94% 0.0% 0.0%
Treasury Stock Shares $2.748M
Shareholders Equity $626.5M $681.0M $728.7M
YoY Change
Total Liabilities & Shareholders Equity $918.7M $964.1M $946.9M
YoY Change -3.54% 1.82% 128.26%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$31.74M -$32.36M -$38.27M
YoY Change -35.66% -15.43% 105.05%
Depreciation, Depletion And Amortization $5.331M $5.511M $4.182M
YoY Change 20.09% 31.78% 42.68%
Cash From Operating Activities -$6.371M $4.692M -$38.26M
YoY Change -843.41% -112.26% 780.08%
INVESTING ACTIVITIES
Capital Expenditures $5.841M $3.784M -$4.561M
YoY Change -233.48% -182.96% 2.26%
Acquisitions
YoY Change
Other Investing Activities $160.0M -$46.76M -$180.6M
YoY Change 966.67% -74.1% -318.85%
Cash From Investing Activities $154.2M -$50.54M -$185.1M
YoY Change 1351.04% -72.7% -337.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -52.60M -$7.682M 4.027M
YoY Change -829.57% -290.76% -10.57%
NET CHANGE
Cash From Operating Activities -6.371M $4.692M -38.26M
Cash From Investing Activities 154.2M -$50.54M -185.1M
Cash From Financing Activities -52.60M -$7.682M 4.027M
Net Change In Cash 95.19M -$53.53M -219.3M
YoY Change 409.33% -75.6% -380.51%
FREE CASH FLOW
Cash From Operating Activities -$6.371M $4.692M -$38.26M
Capital Expenditures $5.841M $3.784M -$4.561M
Free Cash Flow -$12.21M $908.0K -$33.70M
YoY Change -333.37% -102.69% -29919.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001651562
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-40275
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
COURSERA, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-3560292
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
381 E. Evelyn Ave.
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Mountain View
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94041
CY2023Q1 dei City Area Code
CityAreaCode
650
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
963-9884
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.00001 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
COUR
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
150719433 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
267774000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
320817000 usd
CY2023Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
511684000 usd
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
459654000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
381000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
495000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
68199000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
53734000 usd
CY2023Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
23976000 usd
CY2022Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
24147000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17340000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17636000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
888973000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
875988000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26809000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27096000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8409000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9605000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8470000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8553000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
31394000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26355000 usd
CY2023Q1 us-gaap Assets
Assets
964055000 usd
CY2022Q4 us-gaap Assets
Assets
947597000 usd
CY2023Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
93233000 usd
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
66375000 usd
CY2023Q1 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
15969000 usd
CY2022Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
23342000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
17238000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21163000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7865000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8658000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
130902000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
115701000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8636000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7202000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
273843000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
242441000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4208000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5791000 usd
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3259000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3076000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1730000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1714000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
283040000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
253022000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
152932136 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
150184198 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
150683607 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
147935669 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1382487000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1364116000 usd
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2747938 shares
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2747938 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
4701000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
4701000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-285000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-718000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-696487000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-664123000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
681015000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
694575000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
964055000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
947597000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
147642000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
120433000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
70174000 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
42803000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
77468000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
77630000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43809000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37955000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
52872000 usd
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
51667000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25523000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25178000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
-5659000 usd
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
116545000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
114800000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-39077000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-37170000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
8037000 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
335000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
102000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-425000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30938000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37260000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1426000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1008000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-32364000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-38268000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
148974454 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
148974454 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143026907 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
143026907 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-32364000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-38268000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
433000 usd
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1612000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31931000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-39880000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
694575000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5354000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
13036000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26053000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
433000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-32364000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
681015000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
741513000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6450000 usd
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2625000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23227000 usd
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1612000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-38268000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
728685000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-32364000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-38268000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5511000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4182000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
24742000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
21978000 usd
CY2023Q1 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
5016000 usd
CY2022Q1 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-510000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
535000 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1886000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-96000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-233000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14585000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
19997000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5396000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11467000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1197000 usd
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1271000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
19440000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6670000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2476000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1815000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2376000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1557000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
15384000 usd
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
11457000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4692000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38257000 usd
CY2023Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
121756000 usd
CY2022Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
180552000 usd
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
75000000 usd
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
298000 usd
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
400000 usd
CY2023Q1 cour Payments To Capitalized Internal Use Software Costs
PaymentsToCapitalizedInternalUseSoftwareCosts
2862000 usd
CY2022Q1 cour Payments To Capitalized Internal Use Software Costs
PaymentsToCapitalizedInternalUseSoftwareCosts
3544000 usd
CY2023Q1 cour Payments To Acquire Content Assets
PaymentsToAcquireContentAssets
624000 usd
CY2022Q1 cour Payments To Acquire Content Assets
PaymentsToAcquireContentAssets
617000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-50540000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-185113000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5354000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6947000 usd
CY2023Q1 cour Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
0 usd
CY2022Q1 cour Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
295000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
13036000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2625000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7682000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4027000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-53530000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-219343000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
322878000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
582719000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
269348000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
363376000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
267774000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
361315000 usd
CY2023Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1574000 usd
CY2022Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2061000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
269348000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
363376000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1108000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
808000 usd
CY2023Q1 cour Share Based Compensation Capitalized As Internal Use Software
ShareBasedCompensationCapitalizedAsInternalUseSoftware
1311000 usd
CY2022Q1 cour Share Based Compensation Capitalized As Internal Use Software
ShareBasedCompensationCapitalizedAsInternalUseSoftware
1249000 usd
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and related disclosures as of the date of the unaudited condensed consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. We base our estimates on historical experience, current conditions, and various other factors that we believe to be reasonable under the circumstances. Significant items subject to such estimates, judgements, and assumptions include, but are not limited to, those related to the determination of principal versus agent and variable consideration in our revenue contracts; stock-based compensation expense; period of benefit for capitalized commissions; internal-use software costs; useful lives of long-lived assets; the carrying value of operating lease right-of-use assets; the valuation of intangible assets and income tax expense, including the valuation of deferred tax assets and liabilities, among others. Actual results could differ from those estimates, and any such differences could be material to our unaudited condensed consolidated financial statements.</span></div>
CY2022Q4 cour Contract With Customer Expected Incremental Cost Period
ContractWithCustomerExpectedIncrementalCostPeriod
P3Y
CY2023Q1 cour Contract With Customer Expected Incremental Cost Period
ContractWithCustomerExpectedIncrementalCostPeriod
P4Y
CY2023Q1 cour Contract With Customer Amortization On Renewal Period
ContractWithCustomerAmortizationOnRenewalPeriod
P2Y
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentration of credit risk consist of cash, cash equivalents, and marketable securities. We only invest in high-credit-quality instruments and maintain our cash equivalents and marketable securities in fixed-income securities. We place our cash primarily with domestic financial institutions that are federally insured within statutory limits. </span></div>For purposes of assessing concentration of credit risk with respect to accounts receivable and significant customers, we treat a group of customers under common control or customers that are affiliates of each other as a single customer. For the three months ended March 31, 2023 and 2022, we did not have any customers that accounted for more than 10% of our revenue. As of March 31, 2023 and December 31, 2022, we did not have any customers that accounted for more than 10% of our net accounts receivable balance.
CY2023Q1 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
56562000 usd
CY2022Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
45337000 usd
CY2022Q1 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
22286000 usd
CY2023Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
11637000 usd
CY2022Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
8397000 usd
CY2022Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
12110000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
68199000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
53734000 usd
CY2022Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
34396000 usd
CY2023Q1 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
134161000 usd
CY2022Q4 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
118777000 usd
CY2022Q1 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
98488000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
134161000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
118777000 usd
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
98488000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
58733000 usd
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
47160000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
316500000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.65
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q1 cour Commissions And Related Payroll Tax Expenditures
CommissionsAndRelatedPayrollTaxExpenditures
2972000 usd
CY2022Q1 cour Commissions And Related Payroll Tax Expenditures
CommissionsAndRelatedPayrollTaxExpenditures
2493000 usd
CY2023Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
2681000 usd
CY2022Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
2744000 usd
CY2023Q1 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
10387000 usd
CY2022Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
13300000 usd
CY2023Q1 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
13630000 usd
CY2022Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
10426000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
732662000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
122000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
407000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
732377000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
765122000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
26000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
744000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
764404000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
511969000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
511684000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
460372000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
459654000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
71272000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
67158000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
44463000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
40062000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26809000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27096000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
16054000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7584000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8470000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15448000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6895000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8553000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
689000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
643000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2071000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2900000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2372000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
705000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
274000 usd
CY2023Q1 cour Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
148000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8470000 usd
CY2023Q1 us-gaap Sublease Income
SubleaseIncome
0 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.046
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.027
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-32364000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-38268000 usd
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
148974454 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
148974454 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
143026907 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143026907 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
41825241 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29031155 shares
CY2023Q1 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
34898000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
8961000 usd
CY2022Q4 cour Share Based Compensation Arrangement By Share Based Payment Award Rsus Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardRsusOutstanding
22773053 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
14904529 shares
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24742000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21978000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
28536000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
17013403 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
18153195 shares
CY2023Q1 cour Share Based Compensation Arrangement By Share Based Payment Award Rsus Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardRsusOutstanding
24487480 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
8819998 shares
CY2023Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
56405412 shares
CY2022Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
49746246 shares
CY2023Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
856000 usd
CY2022Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
667000 usd
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
147642000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
120433000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
77468000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
77630000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
147642000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
120433000 usd
CY2023Q1 us-gaap Noncurrent Assets
NoncurrentAssets
35218000 usd
CY2022Q4 us-gaap Noncurrent Assets
NoncurrentAssets
36701000 usd
CY2023Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
4800000 usd

Files In Submission

Name View Source Status
cour-20230331_lab.xml Edgar Link unprocessable
0001651562-23-000006-index-headers.html Edgar Link pending
0001651562-23-000006-index.html Edgar Link pending
0001651562-23-000006.txt Edgar Link pending
0001651562-23-000006-xbrl.zip Edgar Link pending
cour-20230331.htm Edgar Link pending
cour-20230331.xsd Edgar Link pending
cour-20230331exx311.htm Edgar Link pending
cour-20230331exx321.htm Edgar Link pending
cour-20230331exx322.htm Edgar Link pending
cour-20230331xex312.htm Edgar Link pending
cour-20230331_cal.xml Edgar Link unprocessable
cour-20230331_def.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
cour-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cour-20230331_htm.xml Edgar Link completed
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending